# Hand grip strength and cognitive dysfunction amongst older Africans in Nigeria

**Authors:** Rufus O. Akinyemi, Oladotun Victor Olalusi, Gabriel Ogunde, Tolulope Akinyemi, Joseph Yaria, Olabode Oguntiloye, Ayotomiwa Fagbemi, Eniola Cadmus, Femi Popoola, Mayowa Ogunronbi, Dorcas Olujobi, Olaoluwa Famuyiwa, Joshua Akinyemi, Mayowa Owolabi, Roman Romero-Ortuno, Adesola Ogunniyi, Raj Kalaria, Brian Lawlor

PMC · DOI: 10.1371/journal.pone.0342598 · PLOS One · 2026-02-27

## TL;DR

This study found that stronger hand grip is linked to better cognitive health in older adults in Nigeria, suggesting a connection between physical and mental health.

## Contribution

The study establishes a novel protective association between hand grip strength and cognitive impairment in an African population.

## Key findings

- Participants with cognitive dysfunction had significantly lower hand grip strength compared to those without.
- Higher hand grip strength was associated with a reduced risk of cognitive impairment after adjusting for multiple factors.
- The protective association of hand grip strength was consistent across age and gender groups.

## Abstract

The relationship between physical and cognitive health among Africans, known for a rising incidence of frailty, cardiometabolic, and cognitive disorders, is unclear. We investigated the relationship between hand grip strength (HGS), and cognitive impairment among older adults in an urban settlement in Ibadan, South West Nigeria.

In this study, we assessed 608 participants from the Vascular heAlth, fraiLty, and cognItion in Ageing Nigerians sTudy [VALIANT] – a population-based cohort of 1021 older persons in Ibadan, a city in Southwestern Nigeria. They were recruited through a multi-stage, stratified cluster random sampling method. Data on HGS were obtained using a digital hand dynamometer while cognitive function was assessed via a consensus diagnosis. The relationship between cognitive impairment and HGS was investigated using a multivariable-adjusted logistic regression analysis.

The mean (SD) age of the study participants was 64.6 ± 11.5 years and 67.6% were females. The proportion of participants with cognitive dysfunction was 22.9%, while the mean (SD) HGS (in kg) was 18.16 (8.06). The mean (SD) HGS was lower among participants with cognitive dysfunction (13.44 ± 5.45) compared to those without cognitive impairment (19.58 ± 8.38; p-value <0.001). After adjustment for age, sex, clinical frailty, level of education, and other metabolic risk markers, high HGS showed a protective association with cognitive impairment, aORs (95%CI) 0.91 (0.87–0.95). This protective association [aORs (95% CI)] was consistent for individuals aged <65 years [0.87 (0.80–0.94] and ≥65 years [0.90 (0.85–0.96)], as well as males 0.88 (0.78–0.99) and females 0.91 (0.84–0.99).

HGS was independently associated with cognitive impairment, buttressing the intricate link between physical and cognitive health in this unique West African population. Future work will explore the predictive ability of grip strength as an early indirect non-invasive biomarker of incident cognitive decline and the utility of targeted resistance training exercises in the primary prevention of neurocognitive disorders.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL15 (interleukin 15) [NCBI Gene 3600] {aka IL-15}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) [NCBI Gene 9146] {aka HRS}
- **Diseases:** Cognitive impairment (MESH:D003072), disability (MESH:D009069), hand/arm weakness (MESH:D053421), slowing of gait speed (MESH:D020234), Dementia (MESH:D003704), CI (OMIM:610141), neurocognitive disorders (MESH:D019965), CVH (MESH:D002318), arthritis (MESH:D001168), hypertension (MESH:D006973), death (MESH:D003643), deficits in both (MESH:D009461), Frailty (MESH:D000073496), decline in muscle mass (MESH:C536030), obesity (MESH:D009765), white matter abnormalities (MESH:D056784), Stroke (MESH:D020521), Deficiency of vitamin D deficiency (MESH:D014808), DM (MESH:D003920), Alzheimer's dementia (MESH:D000544), cardiometabolic (MESH:D024821), sarcopenia (MESH:D055948), inflammatory (MESH:D007249), pain (MESH:D010146), physical (MESH:D059445), dyslipidemia (MESH:D050171)
- **Chemicals:** alcohol (MESH:D000438), calcium (MESH:D002118), glucose (MESH:D005947), lipid (MESH:D008055), 25(OH)D (-), 25-hydroxyvitamin D (MESH:C104450), cholesterol (MESH:D002784), vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12948096/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12948096/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12948096/full.md

---
Source: https://tomesphere.com/paper/PMC12948096